Compare TJX & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TJX | SYK |
|---|---|---|
| Founded | 1962 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.6B | 125.7B |
| IPO Year | 1994 | 1994 |
| Metric | TJX | SYK |
|---|---|---|
| Price | $145.77 | $297.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 29 |
| Target Price | $170.80 | ★ $362.62 |
| AVG Volume (30 Days) | ★ 5.7M | 1.9M |
| Earning Date | 11-18-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.31% | 1.16% |
| EPS Growth | ★ 14.32 | 8.25 |
| EPS | 2.55 | ★ 5.23 |
| Revenue | ★ $29,078,407,000.00 | $25,116,000,000.00 |
| Revenue This Year | $6.06 | $8.24 |
| Revenue Next Year | $6.26 | $8.60 |
| P/E Ratio | ★ $57.62 | $58.27 |
| Revenue Growth | 6.04 | ★ 11.16 |
| 52 Week Low | $122.81 | $267.00 |
| 52 Week High | $170.00 | $389.33 |
| Indicator | TJX | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 57.73 |
| Support Level | $122.81 | $290.96 |
| Resistance Level | $162.20 | $319.17 |
| Average True Range (ATR) | 2.33 | 7.56 |
| MACD | 1.27 | 3.93 |
| Stochastic Oscillator | 82.49 | 76.80 |
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2026, the company generated roughly $60 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.